[ad_1]
British Prime Minister Boris Johnson stated that he expects the Group of Seven (G7) to reach an agreement to implement vaccine passports and start discussions on a global pandemic preparedness treaty at the UK meeting next month.
Johnson told CBC News Chief Political Correspondent Rosemary Button in an exclusive Canadian interview that aired today: “We need to reach an agreement on vaccine passports, COVID identification and other issues.”
“Then some kind of agreement must be reached at the G7 level to start the way of travel and passport work.”
Prime Minister Justin Trudeau said it was premature to discuss the reopening of the country for international travel, but a statement issued by the Prime Minister’s Office after a virtual meeting between the Prime Minister and Trudeau on Thursday said , The discussion on this topic has begun.
The statement said: “During the discussions between the prime ministers, a broad consensus was reached on working together to develop vaccine credentials to reach an international effort based on reasonable principles, including respect for provincial and territorial jurisdiction and the privacy of health information.”
Provinces need to find a way to work with the federal government to solve this problem, because immunization records are kept at the provincial level, while international borders and passport issuance are under federal jurisdiction.
Johnson said that he treats the vaccine certification system or vaccine passport as part of the international pandemic preparedness treaty, which will determine the way to deal with the next pandemic.
Johnson said: “If you look at what happened in the world in 2020, it will be a terrible year for mankind and a terrible year for the international system.” Rosemary Button Live.
“For believers in global cooperation, this is a terrible year, because the world has become desolate and everyone Run for your life. Everyone depends on personal protective equipment for their protective equipment. “
Johnson said that countries around the world have found it difficult to share medicines and vaccines, the methods of isolation and lockdown vary greatly among countries, and the supply chain of basic commodities around the world has also been disrupted.
Johnson added: “We need to establish rules to ensure that cross-border supply will not be interrupted so that we can establish a secure supply chain for the items we depend on in the future.”
Johnson also said that it is vital to ensure that excess vaccine doses ordered by developed countries such as Canada and the United Kingdom are shared with low-income countries as soon as possible.
He said: “No one is safe until everyone is safe.” “What we hope the Group of Seven (G7) can agree to is that instead of vaccinating the world before 2024 or 2025, it is better to vaccinate the world before 2024 or 2025. To achieve this goal on a timetable, we need to complete this work before the end of next year, by 2022.”
The scientific advice we have is [Oxford-AstraZeneca is] A very, very valuable dose, and the benefits are very substantial.-Prime Minister Boris Johnson
Johnson said that his government has reached an agreement with the manufacturer of the Oxford-AstraZeneca vaccine to ensure that the cost of the vaccine is shared with the world.
Johnson pointed out that his government has invested approximately US$1 billion in the COVAX program, and he will work with G7 and Canada to ensure that COVAX is fully funded and to expedite vaccine distribution.
COVAX is a global vaccine sharing program, coordinated by the World Health Organization, Epidemic Prevention Innovation Alliance and Vaccine Alliance Gavi.
The program pools funds from richer countries to purchase vaccines for these countries and ensures that low- and middle-income countries also have access to vaccines.
The federal government bought COVAX for $440 million in September, and pledged another $75 million in February. Of the original 440 million Canadian dollars, half were safe doses for Canadians, and the other half was safe doses for 92 countries that need help to ensure vaccine safety.
Oxford-AstraZeneca
Almost all doses dispensed by COVAX are Oxford-AstraZeneca vaccines, which are associated with rare but potentially fatal blood clots. In Canada, the provinces have stopped the first dose of vaccination, but Johnson said that he is not worried about the safety of the vaccine.
He said: “I will rely entirely on… our medical and health authorities, regulatory authorities.” “They look at these things very carefully. They have taken a very cautious, very cautious approach, and have given us the right to approve. We It is believed that the main benefit to people lies in vaccination.”
Johnson said that despite the UK’s stance on the Oxford-AstraZeneca vaccine, Canadians should follow the medical and scientific advice provided by Canadian officials.
He said: “However, our scientific advice is that this is a very, very valuable dose, and its benefits are very substantial.”
You can watch the entire episode of Rosemary Barton’s live broadcast CBC Gem, CBC’s streaming media service.
[ad_2]
Source link